Navigation Links
Neogen COO resigns
Date:7/18/2014

LANSING, Mich., July 18, 2014 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced today that Stephen Snyder, Neogen's chief operating officer and president, has resigned, effective July 31, 2014. The company said he will work as a consultant going forward on special projects. His resignation is for personal matters.

Snyder has been in this position since September 2013. On an interim basis, his duties will be fulfilled by James Herbert, who has been Neogen's chief executive officer since the company's founding. Neogen's Board of Directors, with Herbert's leadership, is actively recruiting for Snyder's replacement.

Neogen Corporation develops and markets products dedicated to food and animal safety. The company's Food Safety Division markets dehydrated culture media, and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen's Animal Safety Division is a leader in the development of animal genomics, along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care and disinfectants.

CONTACT: Steven J. Quinlan, Vice President & CFO
Neogen Corporation, 517/372-9200


'/>"/>
SOURCE Neogen Corporation
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Neogen licenses Cargill patents
2. Neogen acquires Chem-Tech
3. Neogen reports second quarter results
4. Neogen acquires Prima Tech
5. Neogen shares to be priced Oct. 31
6. Neogen shares begin post-split trading
7. Neogen reports 18% revenue increase
8. Neogen announces 1st quarter results conference call
9. Neogen launches comprehensive dairy heifer genomic test
10. Neogen announces Bohannon retirement, successor named
11. Neogen launches comprehensive cattle genomic test
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
Breaking Biology News(10 mins):